Painful Diabetic Neuropathies Withdrawn Phase 1 / 2 Trials for Benfotiamine (DB11748)

Also known as: Painful Diabetic Neuropathy / Diabetic Neuropathies, Painful / Painful Diabetic Neuropathy (PDN) / Diabetic Neuropathy, Painful; Diabetic Neuropathies / Diabetic Neuropathy, Painful

IndicationStatusPhase
DBCOND0055434 (Painful Diabetic Neuropathies)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01793350Safety and Efficacy Study of BC-DN-01 in Painful Diabetic Peripheral NeuropathyTreatment